- Home
- CMPX vs RDCM Comparison
CMPX vs RDCM Comparison
Compare CMPX & RDCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- RDCM
- Stock Information
- Founded
- CMPX 2014
- RDCM 1985
- Country
- CMPX United States
- RDCM Israel
- Employees
- CMPX 35
- RDCM N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- RDCM Computer peripheral equipment
- Sector
- CMPX Health Care
- RDCM Technology
- Exchange
- CMPX Nasdaq
- RDCM Nasdaq
- Market Cap
- CMPX 291.8M
- RDCM 210.3M
- IPO Year
- CMPX N/A
- RDCM 1997
- Fundamental
- Price
- CMPX $2.11
- RDCM $13.26
- Analyst Decision
- CMPX Strong Buy
- RDCM Strong Buy
- Analyst Count
- CMPX 8
- RDCM 2
- Target Price
- CMPX $13.13
- RDCM $16.00
- AVG Volume (30 Days)
- CMPX 804.2K
- RDCM 62.5K
- Earning Date
- CMPX 05-08-2025
- RDCM 05-14-2025
- Dividend Yield
- CMPX N/A
- RDCM N/A
- EPS Growth
- CMPX N/A
- RDCM 111.69
- EPS
- CMPX N/A
- RDCM 0.53
- Revenue
- CMPX $850,000.00
- RDCM $63,477,000.00
- Revenue This Year
- CMPX N/A
- RDCM $16.58
- Revenue Next Year
- CMPX N/A
- RDCM $11.48
- P/E Ratio
- CMPX N/A
- RDCM $25.35
- Revenue Growth
- CMPX N/A
- RDCM 18.21
- 52 Week Low
- CMPX $0.77
- RDCM $9.05
- 52 Week High
- CMPX $4.08
- RDCM $15.98
- Technical
- Relative Strength Index (RSI)
- CMPX 57.65
- RDCM 58.62
- Support Level
- CMPX $2.06
- RDCM $13.00
- Resistance Level
- CMPX $2.23
- RDCM $13.55
- Average True Range (ATR)
- CMPX 0.12
- RDCM 0.63
- MACD
- CMPX 0.01
- RDCM -0.01
- Stochastic Oscillator
- CMPX 69.23
- RDCM 45.19
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About RDCM Radcom Ltd.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.